SPRAVATO® (esketamine): A Prescription Nasal Spray

https://www.spravato.com/

Last activity: 09.09.2026

Active

Categories: InformationLearn

Learn about SPRAVATO®, the first FDA-approved prescription nasal spray for two depression indications. See full Prescribing & Safety Information, including BOXED WARNING.

Website visits

33.6K /mo.

Mentions

Overview

Employees

11-50

Mentions in press and media 13

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Apr 30, 2026	New Directions Mental Health Expands Services with Spravato® Treatment at Robinson Township Clinic	A look inside the Robinson clinic New Directions Mental Health in Robinson, PA, now offers Spravato®, a fast-acting, FDA-approved treatment for treatment-resistant depression. I'm excited for the hope that Spravato® will bring to clients. W...
Jul 23, 2025	Columbia Mental Health Expands Services with Spravato® Treatment at Bowie, MD Clinic	Inside a Columbia Mental Health clinic Columbia Mental Health offers SPRAVATO®, FDA-approved nasal spray for treatment-resistant depression, providing fast, effective symptom relief. BOWIE, MD, UNITED STATES, July 23, 2025 /EINPresswire.com...
Jun 11, 2025	Innovative Treatment Option for Depression Relief Now Available in Woburn	Northeast Health Services offers SPRAVATO®, FDA-approved nasal spray for treatment-resistant depression, providing fast, effective symptom relief. WOBURN, MA, UNITED STATES, June 11, 2025 /EINPresswire.com/ -- Northeast Health Services is t...
May 19, 2025	Innovative Treatment Option for Depression Relief Now Available in Fox Chapel	New Directions offers SPRAVATO®, FDA-approved nasal spray for treatment-resistant depression, providing fast symptom relief and improved accessibility. PITTSBURGH, PA, UNITED STATES, May 19, 2025 /EINPresswire.com/ -- New Directions Mental ...
Mar 26, 2025	Innovative Treatment Option for Depression Relief Now Available in Greensburg, PA	New Directions Mental Health's Greensburg clinic now offers SPRAVATO®, an FDA-approved nasal spray for fast relief from treatment-resistant depression. GREENSBURG, PA, UNITED STATES, March 26, 2025 /EINPresswire.com/ -- New Directions Menta...
Jan 30, 2025	Depression Relief with Innovative Treatment Option Now at Harmony, Martinsburg	Harmony's Martinsburg clinic now offers SPRAVATO®, an FDA-approved nasal spray for treatment-resistant depression, providing fast-acting symptom relief. MARTINSBURG, WV, UNITED STATES, January 30, 2025 /EINPresswire.com/ -- Harmony, a membe...
Sep 2, 2024	TMS Health and Wellness Expands Access to Revolutionary TMS Therapy for Teens and Adults	Aetna and Medi-Cal now cover TMS therapy for teens 15 years and older, offering accessible, non-drug treatments for anxiety and depression. COSTA MESA, Calif., Sept. 2, 2024 /PRNewswire-PRWeb/ -- TMS Health and Wellness, a premier center fo...
May 29, 2024	Johnson & Johnson pivotal study of seltorexant shows statistically significant and clinically meaningful improvement in depressive symptoms and sleep disturbance outcomes	Seltorexant, an investigational first-in-class therapy, met all primary and secondary endpoints in pivotal Phase 3 study in patients with major depressive disorder (MDD) with insomnia symptoms, as presented at ASCP 2024 Approximately 60 per...
Aug 14, 2023	Psychiatric Mental Health NP, And Spravato Treatment Specialist, Betsy Serrano, Opens New Office in Phoenix	Betsy Serrano NP Treats Some of The Most Difficult Mental Health Issues, Including Treatment Resistant Depression and Opioid Use Disorder I want all to know that there is hope and a solution to mental health disorders, and that they can liv...
Dec 26, 2022	SPRAVATO® Now Available at TMS Health and Wellness For Fast-Acting Relief of Treatment-Resistant Depression in Just Hours	"We’re thrilled to provide Spravato® as a supplemental solution that can work rapidly for those with acute, debilitating depressive symptoms, or symptoms that may result in self-harm." COSTA MESA, Calif. (PRWEB) December 26, 2022 ...
Oct 31, 2022	Indiana Center for Recovery Unveils SPRAVATOⓇ Ketamine Therapy for PTSD and Depression	Indiana Center for Recovery has added ketamine therapy to its award-winning services for Hoosiers and their families, making recovery more accessible. BLOOMINGTON, INDIANA, UNITED STATES, October 31, 2022 /EINPresswire.com/ -- Indiana Cente...
Mar 5, 2019	FDA approves esketamine nasal spray, the first new major depression drug in more than 30 years	In one of the most significant milestones for depression treatment in decades, the U.S. Food and Drug Administration announced today that it has approved a new drug with esketamine, a derivative of ketamine. Made by Johnson & Johnson un...

Reviews 0

FAQ about SPRAVATO® (esketamine): A Prescription Nasal Spray

What has the press written about SPRAVATO® (esketamine): A Prescription Nasal Spray?

Parsers VC has collected 13 articles mentioning SPRAVATO® (esketamine): A Prescription Nasal Spray, among them “New Directions Mental Health Expands Services with Spravato® Treatment at Robinson Township Clinic” (Apr 30, 2026) and “Columbia Mental Health Expands Services with Spravato® Treatment at Bowie, MD Clinic” (Jul 23, 2025).

Is SPRAVATO® (esketamine): A Prescription Nasal Spray still active?

Yes, SPRAVATO® (esketamine): A Prescription Nasal Spray is active; its latest activity on Parsers VC dates from Sep 9, 2026.